Home Is It Just Me? The Nook Edit The World Issue The Brief About Us Contact Us
How Medicaid Drug Pricing Impacts Sexual Health Access
sexual health

How Medicaid Drug Pricing Impacts Sexual Health Access

While Medicaid covers 66 million Americans, unclear drug pricing policies may still leave many struggling to afford essential sexual health medications.

📚 Educational content for informational purposes. Consult a healthcare provider for medical advice.

Key Takeaways

  • Medicaid drug pricing reforms could improve access to sexual health medications.
  • The current voluntary system creates uncertainty for patients needing consistent care.
  • PrEP, contraceptives, and STI treatments are among the medications affected.
46% Increase in Medicaid prescription drug spending 2019-2024

Medicaid's prescription drug spending grew 46% between 2019-2024, reaching $46 billion annually. This growth impacts access to essential sexual health medications including HIV prevention drugs like PrEP, contraceptives, and antibiotics for STI treatment. Many of these medications require consistent use to be effective, making affordability critical.

The proposed 'most favored nation' pricing would theoretically lower costs for Medicaid recipients, but the voluntary nature means coverage gaps persist. Birth control pills that cost $30 in Canada might still be $150+ for some U.S. Medicaid patients depending on their state's participation in the program. Similar disparities exist for PrEP, which can cost over $20,000 annually without proper coverage.

HIV advocates note that inconsistent drug pricing creates barriers to consistent prevention and treatment. The CDC estimates that only 25% of Americans who could benefit from PrEP currently receive it, with cost being a significant factor. Similar challenges exist for those needing antibiotics for STIs like syphilis, which has seen a 74% increase in cases since 2017.

"Medicaid covers 66 million Americans, but drug pricing uncertainty leaves many struggling to afford medications."

Why This Matters

Affordable access to sexual health medications directly impacts public health outcomes. When people can't afford preventive medications like PrEP or contraceptives, rates of HIV and unintended pregnancies increase. Studies show that eliminating copays for contraceptives under Medicaid increases consistent use by 22%.

The current voluntary pricing system creates a patchwork of access that particularly disadvantages marginalized communities. Black and Latinx Americans are disproportionately affected by both HIV and Medicaid coverage gaps. Transgender patients on Medicaid often face additional barriers accessing gender-affirming care that interacts with their sexual health needs.

What You Can Do

If you're on Medicaid, check with your state health department about medication assistance programs that may exist beyond the federal reforms. Many pharmaceutical companies offer patient assistance programs for specific medications like PrEP (Gilead's Advancing Access program) or hormonal therapies.

Advocate for more transparent drug pricing policies by contacting your state Medicaid office and federal representatives. Organizations like Planned Parenthood and the National Alliance of State and Territorial AIDS Directors (NASTAD) track how pricing changes affect sexual health access and need public support.

Learn More

Related topics on The Nookie Nook: sexual health

Share this story
WhatsApp X

Sources

NPR Health

Frequently Asked Questions

Does Medicaid cover all sexual health medications?

Medicaid covers most FDA-approved contraceptives and many STI treatments by law, but specific drugs and copays vary by state based on their formularies and participation in pricing reforms.

How can I find affordable PrEP if my Medicaid plan won't cover it?

Gilead's Advancing Access program provides free PrEP to qualifying individuals, and many community health centers offer sliding-scale fees regardless of insurance status.

Do these drug pricing changes affect emergency contraception?

Potentially yes, as emergency contraception (Plan B) is classified as an OTC drug but sometimes prescribed through Medicaid - pricing reforms could lower costs at participating pharmacies.

Want To Stay Curious ?

Get notifications for the updates on recommendations, new research and stories delivered to your inbox.